Table 1.

Demographic and Clinical Characteristics of Patients with ESBL-Positive UTIs

Characteristic	E. coli (n=344)	K. pneumoniae (n=122)	P-value*
Age, mean (SD), y	67 (21)	74 (18)	0.001
Female	210 (61)	72 (59)	0.668
T2DM	179 (63)	85 (77)	0.421
CKD	64 (19)	53 (43)	0.205
Laboratory data
HbA1C, mean (SD), %	7.25 (3)	7.29 (2)	0.959
Albumin, mean (SD), g/dL	28.54 (5)	28.28 (5)	0.706
Hemoglobin, mean (SD), g/dL	10.94 (1)	10.85 (1)	0.544
Leukocyte, mean (SD)	10.09 (4)	9.76 (4)	0.512
Neutrophils, mean (SD)	7.30 (5)	7.00 (6)	0.741
Lymphocytes, mean (SD)	1.98 (3)	2.82 (6)	0.051
Procalcitonin, mean (SD)	0.16 (0.1)	0.15 (0.1)	0.712
Platelet count, mean (SD)	269 (108)	274 (141)	0.696
Antibiotic sensitivity
β-lactam/β-lactamase inhibitor
Amoxicillin-clavulanate	224 (65)	64 (52)	0.015
Piperacillin-tazobactam	315 (92)	101 (83)	0.026
Carbapenem
Meropenem	336 (98)	119 (97)	0.640
Ertapenem	323 (94)	108 (88)	0.196
Other
Ciprofloxacin	93 (27)	49 (40)	0.000
Nitrofurantoin	324 (94)	57 (47)	0.000
Gentamycin	218 (63)	95 (78)	0.000
Trimethoprim/Sulfamethoxazole	146 (42)	34 (28)	0.005

Notes: *Statistical significance: P ≤ 0.05.